UK-based biopharmaceutical company AstraZeneca has announced a $3.5bn ... a new biologics manufacturing facility in Maryland and expand specialty manufacturing in Texas. Additionally, it will ...
Outside of Massachusetts, AstraZeneca said its expanding U.S. footprint includes a manufacturing facility for biologics in Maryland, cell therapy manufacturing capacity on the West and East Coasts ...
AstraZeneca made headlines for several reasons on Tuesday ... The investment will also support creation of a new next generation manufacturing facility, focused on biologics, in Maryland as well as ...
AstraZeneca has announced a major expansion ... spend $2bn to bolster its manufacturing capacity in states including Maryland and Texas as well as on the west coast. This would bring its total ...
AstraZeneca’s expanding footprint in the ... Massachusetts A next generation manufacturing facility for biologics in Maryland Cell therapy manufacturing capacity on the West and East Coasts ...
The new investments will expand manufacturing sites in Maryland, Texas and California. But AstraZeneca shares have fallen nearly 6% this year, underperforming a near 9% rise in the wider European ...